← Front pageReports · Watch · Archive
DRASKER

DRASKER REPORT

published · Updated November 13, 2026

Means’s MAHA allegations: what records show

Means had left government before the interviews, and his allegations covered several distinct policy disputes, from children’s diets to vaping and glyphosate. The accounts available describe competing explanations for some episodes, including anonymous reporting about pressure to speed FDA nicotine-application reviews and named denials that anyone promoted particular flavored-vape products.7,11,12,20

KEY POINTS
  • Calley Means accused Susie Wiles and other senior Trump advisers of putting industry interests ahead of Make America Healthy Again policies in the run-up to the midterms. In a Nov. 8, 2026, CBS “Face the Nation” interview, he named vaping, ultra-processed food, pharmaceuticals and pesticides, and alleged that advisers catered to those industries for fundraising money.3
  • In a Joe Rogan interview published Nov. 6, 2026, Calley Means accused Susie Wiles of putting midterm fundraising ahead of health policy, saying she withheld support for his efforts to improve children’s diets because she needed sugar-industry money. The New York Times quoted Means as saying Wiles told him, “We need money for the midterms, Calley.”9
  • July 9, 2025: A White House video identified Susie Wiles as chief of staff, establishing an official date by which she held the position.24
  • On Nov. 8, Means made a separate allegation about a proposed federal definition of ultra-processed food. He said Fabrizio advised against pursuing it, describing the policy as having 90% support and quoting Fabrizio as saying “the juice isn’t worth the squeeze”; Means also said Pepsi and Pfizer appeared on Fabrizio’s client list. CBS’s transcript preserves Means’s account, but it does not include the poll underlying the 90% figure or records showing that either company paid Fabrizio for advice connected to the policy.21
  • The vaping dispute combines an FDA action, reported lobbying and competing accounts of what administration officials were asked to do. Newsweek reported that in early May the FDA authorized Glas Inc. to market mango- and blueberry-flavored nicotine pods, along with two menthol varieties—a first for fruit flavors. CBS News reported that the FDA’s May guidance potentially allowed major tobacco companies to sell flavored vapes. CBS also reported that President Trump tasked James Blair with pressing then-FDA Commissioner Marty Makary to respond faster to nicotine-industry applications, citing two unnamed people familiar with the process. That account concerns processing speed; it does not establish that Blair advocated for specific flavored products. [newsweek-reports-that-in-early-may-the-fda-authorized-glas-inc-to-market-mango-and-blueberry-flavored-nicotine-pods-plus] [two-sources-familiar-with-the-process-told-cbs-news-that-blair-was-tasked-by-president-trump-with-pushing-then-fda-commi]11,12,13
WHAT WE KNOW

Calley Means accused Susie Wiles and other senior Trump advisers of putting industry interests ahead of Make America Healthy Again policies in the run-up to the midterms. In a Nov. 8, 2026, CBS “Face the Nation” interview, he named vaping, ultra-processed food, pharmaceuticals and pesticides, and alleged that advisers catered to those industries for fundraising money.3

Wiles, James Blair, Brian Ballard and Tony Fabrizio denied allegations or specific accounts attributed to them. CBS News reported lobbying revenue and client relationships involving Ballard Partners, alongside a chronology of FDA vape guidance and tobacco-industry contacts; those reported ties and events do not establish that financial relationships caused a policy decision.1,2

A CBS News summary says Means answered “Yes” when asked whether his allegations led to Wiles’s departure; the published interview transcript instead records him answering “Yes” when asked whether he intended to get her removed, then saying he had “no idea” whether his allegations were a factor. The accounts conflict on his answer about causation.21,23

What Means alleges—and what he does not prove

In a Joe Rogan interview published Nov. 6, 2026, Calley Means accused Susie Wiles of putting midterm fundraising ahead of health policy, saying she withheld support for his efforts to improve children’s diets because she needed sugar-industry money. The New York Times quoted Means as saying Wiles told him, “We need money for the midterms, Calley.”9

On CBS’s “Face the Nation” on Nov. 8, Means broadened the accusation to a group that included Wiles, Richard Walters, Walker Barrett and James Blair. He alleged they catered to the vaping, ultra-processed-food, pharmaceutical and pesticide industries for midterm fundraising money, and said the president did not fully know what was happening. Means presented this as a firsthand account of conversations and events he said he witnessed; his conclusion that the advisers acted for fundraising reasons is his interpretation of them.21

Means also alleged that pollster Tony Fabrizio advised against defining ultra-processed food as a policy priority, saying “the juice isn’t worth the squeeze,” while Fabrizio was being paid by Pepsi and Pfizer. Means said the companies appeared on Fabrizio’s client list; the interview records his assertion, not payment documentation.21

Means’s account also separates his stated aim in going public from what he knows about the staff change: he said he intended to get Wiles removed, but said he had “no idea” whether his allegations factored into her departure.21

From policy disputes to the staff change

July 9, 2025: A White House video identified Susie Wiles as chief of staff, establishing an official date by which she held the position.24

Nov. 6, 2026: Trump announced that Stephen Miller would replace Wiles as chief of staff and that Wiles would move to the Trump Political Operation. Wiles said on X that Friday was her last day as chief of staff.9,19

CBS News reported, citing a U.S. official and a senior White House adviser, that Wiles submitted her resignation Thursday night. The outlet cited three sources familiar with the matter for the account that her resignation was tied to Republicans’ midterm defeats, while noting it was unclear whether Means’s public remarks factored into the decision.11

On Nov. 6, the White House also published a video page identifying Miller as chief of staff; the page gives no reason for the staffing change.25

Sugar and ultra-processed-food policy

For the children’s-diet dispute, Means’s specific account is that Wiles withheld support for his efforts to improve children’s diets because she said money from the sugar industry was needed for the midterms. Means quoted her as telling him, “We need money for the midterms, Calley,” in the Joe Rogan interview published Nov. 6, 2026. The New York Times reported his account; the available claims identify no policy draft, meeting record, fundraising communication or independent witness that documents the exchange or a resulting decision.9,26

On Nov. 8, Means made a separate allegation about a proposed federal definition of ultra-processed food. He said Fabrizio advised against pursuing it, describing the policy as having 90% support and quoting Fabrizio as saying “the juice isn’t worth the squeeze”; Means also said Pepsi and Pfizer appeared on Fabrizio’s client list. CBS’s transcript preserves Means’s account, but it does not include the poll underlying the 90% figure or records showing that either company paid Fabrizio for advice connected to the policy.21

Fabrizio responded after the broadcast that the allegation he was “in the pocket of Big Pharma” was “demonstrably false” and said he had encouraged Republican members of Congress to campaign on the MFN drug-pricing issue. That statement contests Means’s characterization; the available material does not include Fabrizio’s underlying client or payment records, a policy draft, or documentation of the conversation Means described.3

The records needed to test the children’s-diet account would include dated drafts, decision or meeting records, and communications among Means, Wiles and anyone involved in fundraising.9

For the ultra-processed-food proposal, relevant records would include the proposal and polling Means cited, a record of Fabrizio’s advice, and documentation of the client relationships and any work performed; the cited interview claims do not provide those materials.21

Vaping, kratom, pesticides and FDA/HHS claims

The vaping dispute combines an FDA action, reported lobbying and competing accounts of what administration officials were asked to do. Newsweek reported that in early May the FDA authorized Glas Inc. to market mango- and blueberry-flavored nicotine pods, along with two menthol varieties—a first for fruit flavors. CBS News reported that the FDA’s May guidance potentially allowed major tobacco companies to sell flavored vapes. CBS also reported that President Trump tasked James Blair with pressing then-FDA Commissioner Marty Makary to respond faster to nicotine-industry applications, citing two unnamed people familiar with the process. That account concerns processing speed; it does not establish that Blair advocated for specific flavored products. [newsweek-reports-that-in-early-may-the-fda-authorized-glas-inc-to-market-mango-and-blueberry-flavored-nicotine-pods-plus] [two-sources-familiar-with-the-process-told-cbs-news-that-blair-was-tasked-by-president-trump-with-pushing-then-fda-commi]11,12,13

Means alleged that Wiles and Blair pushed HHS to find a pathway for fruit-flavored vapes; Blair told CBS News he did not promote flavored vaping specifically and was tasked with making the FDA process nicotine-device applications within the six-month timeline required by law. Separately, CBS News reported that Blair spoke with Reynolds and other vape companies about the application process, but not particular applications or products. [calley-means-told-face-the-nation-that-susie-wiles-and-her-deputy-james-blair-relentlessly-pushed-hhs-to-find-a-pathway-] [james-blair-in-a-direct-statement-to-cbs-news-denied-promoting-flavored-vaping-saying-he-was-tasked-with-making-the-fda-] [cbs-news-reports-citing-two-unnamed-sources-familiar-with-the-conversations-that-james-blair-spoke-with-reynolds-and-oth]1,12,20

CBS News reported that the May guidance came a week after Brian Ballard and tobacco executives lunched with President Trump in Jupiter, Florida, an account CBS attributed to The New York Times. CBS also reported that RAI Services Company gave $5 million to MAGA Inc. on April 30, citing FEC records. Brian Ballard said no one at his firm advocated to Wiles or White House staff on fruit-flavored-vape authorization, and Wiles said she had nothing to do with the meeting. The chronology documents proximity, not a causal link between the contribution or lunch and FDA guidance. [cbs-news-reports-that-the-fdas-may-guidance-potentially-allowing-flavored-vapes-came-a-week-after-brian-ballard-and-toba] [named-parties-denied-the-allegations-on-the-record-brian-ballard-said-in-a-statement-that-no-one-at-his-firm-advocated-t]2

Makary told CBS News that the tobacco and Kratom/7-OH lobbies pressured him through administration and HHS connections to approve fruit-flavored vapes and block his effort to restrict kratom products, and that he refused. His statement supports that he described pressure; it does not identify Wiles, Blair or Ballard as directing it, or establish that pressure changed policy. [marty-makary-stated-in-a-statement-to-cbs-news-that-big-tobacco-and-the-kratom-7-oh-lobby-pressured-him-through-administ]12

On glyphosate, The Daily Caller, citing the Federal Register, reported that Trump signed Executive Order 14387 on Feb. 18, invoking the Defense Production Act to secure domestic supplies of glyphosate-based herbicides and elemental phosphorus. Means alleged that Walker Barrett presented a draft order and told him the matter was “not up for discussion”; that reported account does not independently establish who drafted or shaped the order, or why. [daily-caller-reports-citing-the-federal-register-that-president-trump-signed-executive-order-14387-on-feb-18-invoking-th] [daily-caller-reports-that-in-his-taped-face-the-nation-interview-means-said-wiles-told-him-she-needed-sugar-industry-mon]22

Means also alleged that industry pressure led to glyphosate’s omission from a later MAHA report and that the White House sided with Bayer in an amicus brief in Monsanto v. Durnell. Politico reported, citing an unnamed White House official, that the Supreme Court had requested the solicitor general’s view and that Overton was not involved in drafting the brief, suggesting only minor tone changes after it had been written. Politico’s account attributes that description of Overton’s role to the official; it does not resolve Means’s broader allegation about industry pressure or the administration’s position. [politico-reports-means-allegation-that-a-second-maha-report-omitted-glyphosate-due-to-industry-pressure-on-wiles-and-tha] [politico-reports-citing-an-unnamed-white-house-official-that-heidi-overton-was-not-involved-in-drafting-the-supreme-cour]4

On pharmaceuticals, Means alleged that Overton told Makary she could not help him on other policies unless he approved Moderna’s mRNA flu vaccine, mFLUSIVA. CBS News reported the allegation but did not provide independent corroboration of the alleged exchange. The Federalist attributed to Means a separate allegation that Ballard Partners helped secure approval of Moderna’s vaccine despite an allegedly flawed trial; that report provides no independent documentation connecting the firm to the approval or showing that lobbying determined the outcome. [calley-means-alleged-that-white-house-adviser-heidi-overton-told-former-fda-commissioner-dr-marty-makary-that-she-couldn] [the-federalist-reports-citing-means-that-ballard-partners-described-as-a-wiles-linked-lobbying-firm-succeeded-in-getting]10,12

What the lobbying records show—and don’t

CBS News said its analysis of Senate lobbying disclosures found that Ballard Partners reported more than $88 million in lobbying revenue in 2025, the highest total it identified since the Lobbying Disclosure Act took effect in 1996, and more than $98 million through the first three quarters of 2026. Those figures are the outlet’s analysis of filings; the underlying filings are not reproduced in the material reviewed here. [a-cbs-news-analysis-of-senate-lobbying-disclosures-found-ballard-partners-reported-more-than-88-million-in-lobbying-reve]1,2

CBS News reported that RAI Services Company, a Reynolds American subsidiary, had paid Ballard Partners millions of dollars since 2017, and that Bayer had paid the firm since January 2024. These reported client relationships do not identify particular payments for specific policy work. [per-a-cbs-news-analysis-of-senate-lobbying-disclosures-ballard-partners-reported-more-than-88-million-in-lobbying-revenu]2

A separate report by The Gateway Pundit, relaying a May 2025 finding by Public Citizen, said six former Wiles clients had reported lobbying White House offices during the administration’s first three months, including companies in tobacco, automobile and fertilizer industries. The Gateway Pundit noted that those disclosures show lobbying relationships, not that Wiles improperly favored the companies. [the-gateway-pundit-reports-that-in-may-2025-the-watchdog-organization-public-citizen-identified-six-former-susie-wiles-c]5

The denials—and what each addresses

Susie Wiles’s spokesperson called Means’s accusations “outrageous, defamatory, and provably false.” Wiles also told CBS News she had nothing to do with the tobacco-industry meeting at President Trump’s Florida golf club, and denied arranging for tobacco representatives to meet Trump there about vape policy. Those denials address the alleged meeting and the accusations generally; they do not supply a detailed account of Means’s alleged private conversations about sugar policy. [a-spokesperson-for-susie-wiles-told-axios-that-calley-means-accusations-are-outrageous-defamatory-and-provably-false-add] [susie-wiles-in-a-statement-to-cbs-news-denied-means-allegation-that-she-arranged-for-tobacco-industry-representatives-to]11,18

James Blair told CBS News he did not promote flavored vaping and was tasked with making the FDA process nicotine applications within the six-month statutory timeline. He called Means’s characterization a “complete and total lie.” Politico quoted Blair saying he did not know what Means was talking about and citing his work confirming Robert F. Kennedy Jr. and removing a pesticide-liability shield from an appropriations bill. Separately, CBS News reported that two sources familiar with the process said Blair was tasked with pressing then-FDA Commissioner Marty Makary to respond faster to nicotine-industry applications; that account concerns application timing, not proof Blair advocated for a particular product. [james-blair-in-a-direct-statement-to-cbs-news-denied-promoting-flavored-vaping-saying-he-was-tasked-with-making-the-fda-] [james-blair-directly-denied-the-allegations-to-politico-saying-i-have-literally-no-idea-what-calley-means-is-talking-abo] [two-sources-familiar-with-the-process-told-cbs-news-that-blair-was-tasked-by-president-trump-with-pushing-then-fda-commi]4,11,12,20

Brian Ballard said no one at Ballard Partners advocated to Wiles or White House staff for fruit-flavored vape authorization, and denied that the firm lobbied Wiles or West Wing staff on glyphosate. He described the firm’s interactions with Wiles as chief of staff as limited and said its vape work concerned illegal Chinese products. Ballard’s statements dispute Means’s account; the reporting cited here does not resolve the disputed contacts. [named-parties-denied-the-allegations-on-the-record-brian-ballard-said-in-a-statement-that-no-one-at-his-firm-advocated-t] [brian-ballard-issued-a-statement-denying-that-anyone-at-ballard-partners-advocated-to-wiles-or-white-house-staff-for-fru]2,18

Tony Fabrizio called Means’s allegation that he was “in the pocket of Big Pharma” “ridiculous” and “demonstrably false.” Fabrizio said he had encouraged Republican members of Congress to campaign on the most-favored-nation drug-pricing issue. The transcript records Means’s assertion that Pepsi and Pfizer appeared on Fabrizio’s client list, but does not establish that either company paid him for work related to the advice Means described. [cbs-news-reports-that-tony-fabrizio-released-a-statement-after-the-broadcast-calling-means-allegations-that-he-is-in-the] [means-alleged-that-fabrizio-while-advising-against-a-90-support-ultra-processed-food-definition-policy-the-juice-isnt-wo]3,21

The Daily Caller reported that a Continental Strategy spokesperson, speaking for Katie Wiles, called Means’s claims about the firm “inaccurate and baseless.” The Daily Caller did not provide the firm’s client list or an account from Katie Wiles herself. [the-daily-caller-reports-that-a-continental-strategy-spokesperson-speaking-for-katie-wiles-called-the-claims-about-that-]22

The CBS transcript records Wiles’s statement that Trump had done more for the MAHA agenda than any previous president. Richard Walters is identified in CBS’s editorial note as having told the network he submitted his resignation; the note does not address Means’s allegations. No on-record response from Walker Barrett appears in the reporting cited here. [per-a-cbs-news-editorial-note-in-the-transcript-richard-walters-told-cbs-news-he-submitted-his-resignation-friday-and-su] [the-gateway-pundit-reports-that-ballard-partners-issued-a-statement-on-november-8-2026-firmly-denying-the-allegations-po]3,5

At her Sept. 24, 2026, Senate confirmation hearing, Heidi Overton declined to say whether she would push back on President Trump’s interventions in tobacco policy or on false statements about vaccines or Tylenol, telling senators she had had “robust” discussions with him and that he wanted the best for Americans. The New York Times reported that she pledged to communicate that currently approved vaccines are safe and effective. These were Overton’s stated positions at the hearing; they do not address Means’s specific allegations about her interactions with Makary or the glyphosate brief. [the-new-york-times-reports-that-dr-heidi-overton-president-trumps-nominee-to-run-the-fda-declined-at-her-sept-24-2026-se] [the-new-york-times-reports-that-under-sharp-questioning-at-the-hearing-overton-pledged-to-communicate-that-currently-app]8

Oversight is a stated possibility, not a documented formal inquiry

Attorney General Todd Blanche said the Justice Department would not investigate “something that someone says on a podcast.” In a separate CNN appearance, Blanche called Means a “disgruntled former administration official”; those remarks record his response, not a finding about the allegations. [cbs-news-reports-that-incoming-house-oversight-chairman-rep-robert-garcia-said-he-will-look-into-the-claims-against-wile] [california-rep-robert-garcia-the-incoming-house-oversight-committee-chairman-said-he-will-look-into-the-claims-against-w]1,2

Rep. Robert Garcia, the incoming House Oversight chairman, said he would look into the allegations. On CNN’s “State of the Union,” Garcia said they “should be investigated” and that his committee was “looking at this very case”—a statement of intent, not an announcement of a formally opened inquiry. [rep-robert-garcia-d-calif-incoming-chair-of-the-house-oversight-committee-said-on-cnns-state-of-the-union-that-the-alleg]6

Garcia’s later descriptions varied: The Epoch Times quoted him on Nov. 10 saying the committee had “already been looking at” Wiles and that he expected action from other committees; The Baltimore Sun’s Nov. 12 account quoted him saying, “We’ve already been looking at Susie Wiles,” while describing the committee as weighing an investigation. The cited accounts do not document a formal inquiry, records requests or subpoenas. [rep-robert-garcia-d-calif-said-on-nov-10-2026-that-the-house-oversight-committee-had-already-been-looking-at-susie-wiles] [rep-robert-garcia-d-calif-told-reporters-on-capitol-hill-the-week-of-november-12-2026-weve-already-been-looking-at-susie] [the-articles-headline-and-framing-present-the-house-oversight-committee-as-weighing-an-investigation-into-wiles-per-garc]15,17

HuffPost’s headline characterized the committee as having “already begun investigating”; its account quoted Garcia saying it had “already been looking at” Wiles. [huffpost-reports-that-rep-robert-garcia-ranking-member-of-the-house-oversight-committee-said-on-tuesday-that-the-house-o]16

White House counsel Will Scharf warned Garcia in a Nov. 9 letter that any congressional investigation of administration officials must have “a legitimate legislative purpose,” or it would amount to “a clear abuse of power.” [white-house-counsel-will-scharf-warned-garcia-in-a-nov-9-letter-that-any-congressional-investigation-of-administration-o]15

Evidence matrix: what is documented and what remains disputed

The CBS transcript documents that Means made the allegations and that named parties responded; it does not independently establish the private conversations or motives he described.3,11

For lobbying, CBS News’s analysis of Senate disclosures reports firm revenue and client relationships; those records, as described by CBS, document business ties, not a payment for a particular policy result. The Gateway Pundit’s account of Public Citizen’s 2025 finding likewise describes former clients lobbying White House offices, while noting that the relationships do not establish favoritism by Wiles.1,2,5

For the vape-policy sequence, CBS News reports the donation, lunch and FDA guidance chronology, alongside the White House’s denial that the donation affected the decision and Ballard’s and Wiles’s denials of the alleged contacts. These accounts document reported events and responses; they do not establish a causal link between the donation, meeting and guidance.1

CBS News, citing two sources familiar with the process, reported that Blair was tasked by Trump to press Makary to respond faster to nicotine-industry applications, while acknowledging Trump’s interest in greater availability of flavored vapes. Blair denied promoting flavored vaping and said his task was to ensure the FDA followed the statutory application timeline.11,12,20

For the sugar-policy allegation, the cited reporting records Means’s account of a private exchange, but supplies no contemporaneous record or independent witness to it. For Fabrizio, the transcript records Means’s assertion about advice and clients and Fabrizio’s denial; it does not include payment records establishing the alleged relationships or a connection to policy advice.3,9

For glyphosate, the Federal Register account cited by The Daily Caller documents an executive order, while Means’s account of Barrett’s remarks is an allegation about how it was presented internally. Ballard denied lobbying Wiles or West Wing staff on the glyphosate order. The cited material does not document the alleged exchange or connect Ballard to the order’s outcome.18,22

For the Moderna vaccine allegation, CBS News records Means’s account of an alleged exchange involving Overton and Makary; the material does not include a contemporaneous record or an independent witness to it. The Federalist separately relayed Means’s allegation that Ballard Partners helped secure approval, without supplying independent documentation of the firm’s role.10,12

The matrix therefore separates reported records and policy events from attributed accounts of private conversations, and keeps denials beside the allegations they address. CBS News reported the revenue and client relationships; Means supplied the claims about specific exchanges and influence; named parties disputed several of those accounts. The material cited in this section does not establish that a lobbying relationship or donation bought a White House policy outcome.1,2,21

What would establish—or refute—a policy-for-payment link

The records CBS News summarized on Ballard Partners’ lobbying revenue and clients, and its account of the timing around FDA vape guidance, establish why the relationships merit examination; they do not by themselves show that a payment or lobbying contact changed a decision. [per-cbs-news-analysis-of-senate-lobbying-disclosures-ballard-partners-reported-more-than-88-million-in-lobbying-revenue-] [cbs-news-reports-that-the-fdas-may-flavored-vape-guidance-came-a-week-after-brian-ballard-and-tobacco-executives-lunched]1

For the vape guidance and Executive Order 14387, the key test would be whether contemporaneous decision records—such as drafts and revisions, internal explanations, meeting calendars, visitor logs and communications—show a request from a named firm, donor or adviser reaching the officials responsible for the decision and affecting its terms or timing. CBS News’ account identifies a reported chronology and denials, but does not supply those underlying decision records. [cbs-news-reports-that-the-fdas-may-flavored-vape-guidance-came-a-week-after-brian-ballard-and-tobacco-executives-lunched]1

The financial side would require the underlying lobbying and campaign-finance filings, plus records identifying the clients, work, dates and recipients relevant to each policy. CBS News’ analysis reports firm revenue and client ties, but those figures alone do not identify a payment for a particular intervention or establish that a policy outcome followed from it. [per-cbs-news-analysis-of-senate-lobbying-disclosures-ballard-partners-reported-more-than-88-million-in-lobbying-revenue-]1

Evidence against the alleged chain would include records showing the relevant officials did not communicate about the decision, that the policy rationale and drafting predated any alleged intervention, or that the decision followed an independently documented process. Ballard denied that his firm advocated to Wiles or White House staff on flavored-vape authorization, while CBS News reported that the White House said the donation had nothing to do with the FDA decision; those responses are relevant to test, but the reporting does not independently resolve the dispute. [cbs-news-reports-that-the-fdas-may-flavored-vape-guidance-came-a-week-after-brian-ballard-and-tobacco-executives-lunched]1

Bottom line: the causal link remains unproved

The record supports a narrower conclusion than either a finding of improper influence or a finding that no such influence occurred: reported business ties and policy events do not, without evidence connecting a request to a decision, establish a policy exchange. [per-a-cbs-news-analysis-of-senate-lobbying-disclosures-ballard-partners-reported-more-than-88-million-in-lobbying-revenu]2

That connection remains an open question for the sugar and ultra-processed-food allegations, the claimed contacts involving Continental Strategy and Katie Wiles, and Means’s assertions about Fabrizio’s clients: the available material does not establish the alleged exchanges or show that a financial relationship determined a policy decision. [calley-means-said-on-cbss-face-the-nation-nov-8-2026-that-a-policy-defining-ultra-processed-food-with-90-support-was-adv] [the-daily-caller-reports-that-a-continental-strategy-spokesperson-speaking-for-katie-wiles-called-the-claims-about-that-] [in-the-same-interview-means-alleged-that-pollster-tony-fabrizio-whose-outside-firm-the-white-house-relies-on-advi]21,22

The departure’s cause remains unresolved: the available accounts do not establish that Means’s allegations caused or materially contributed to Wiles’s exit. [cbs-news-reports-citing-a-u-s-official-and-a-senior-white-house-adviser-that-wiles-submitted-her-resignation-thursday-ni]11

The material uncertainties are consequential: whether primary filings and communications would document the alleged financial relationships and contacts, whether those contacts affected particular decisions, and whether formal oversight steps follow lawmakers’ statements. [idaho-public-press-states-that-the-available-reporting-provides-no-independent-evidence-resolving-means-claims-about-par] [the-gateway-pundit-does-not-report-any-congressional-committee-investigation-records-request-or-subpoena-into-susie-wile]5,14

TIMELINE
  1. A White House video identified Susie Wiles as chief of staff.24

  2. The Daily Caller, citing the Federal Register, reported that President Trump signed Executive Order 14387, invoking the Defense Production Act to support domestic supply of glyphosate-based herbicides and elemental phosphorus.22

  3. CBS News reported, citing FEC records, that RAI Services Company gave $5 million to MAGA Inc.1

  4. CBS News reported that FDA guidance potentially allowing flavored-vape sales came a week after a lunch involving Brian Ballard, tobacco executives and President Trump in Jupiter, Florida; CBS attributed the lunch account to The New York Times. CBS News reported that the White House said the donation had nothing to do with the FDA decision.1

  5. Newsweek reported that the FDA authorized Glas Inc. to market mango- and blueberry-flavored nicotine pods, along with two menthol varieties.13

  6. The New York Times reported that FDA nominee Heidi Overton declined at her Senate confirmation hearing to say whether she would push back on President Trump’s tobacco-policy interventions or false statements about vaccines or Tylenol; Overton said she had had “robust” discussions with the president.8

  7. The New York Times reported that Means’s Joe Rogan interview was published and that Trump announced Wiles would leave the chief-of-staff role, with Stephen Miller replacing her. The New York Times reported that Wiles was to leave Monday; People reported that Wiles said Nov. 6 was her last day as chief of staff. The announcement date and reported effective date therefore differ across accounts.9,19

  8. On Nov. 6, CBS News reported, citing a U.S. official and a senior White House adviser, that Wiles submitted her resignation Thursday night, Nov. 5. CBS also cited three people familiar with the matter who said the move was tied to Republican midterm defeats, and said it was unclear whether Means’s remarks factored into the decision.11

  9. On CBS’s “Face the Nation,” Means said it was his intention to get Wiles removed, but said he had “no idea” whether his allegations were a factor in her departure.21

  10. White House counsel Will Scharf warned Rep. Robert Garcia in a letter that any congressional investigation of administration officials needed a “legitimate legislative purpose.”15

  11. Rep. Robert Garcia said the House Oversight Committee had “already been looking at” Wiles and that he expected action from other committees; the account did not document a formal inquiry, records request or subpoena.15

  12. Garcia told reporters, “We’ve already been looking at Susie Wiles,” and said he expected action from other committees. The Baltimore Sun described the committee as weighing an investigation, not as having formally opened one.17

WHAT WE STILL DON'T KNOW
  • Raw LDA/FEC filings and the Public Citizen report behind the Wiles-client and Ballard revenue claims; the available reporting has news summaries, not primary records.
  • Continental Strategy/Katie Wiles: LDA client list, any White House/HHS contacts, and a first-hand firm statement.
  • Walker Barrett's response; he is named repeatedly but no on-record response appears in the reporting Drasker has located.
  • Documentation for Means's claim that Fabrizio was paid by Pepsi/Pfizer beyond Means's assertion.
  • Whether any congressional committee has formally opened an inquiry, issued records requests or subpoenas, as distinct from Garcia's stated intentions.
  • Whether any record ties EO 14387, the FDA Glas authorization or May vape guidance to Wiles, Blair or Ballard beyond chronology.
  • The underlying LDA/FEC filings and Public Citizen report cited in coverage are not available in the material reviewed.
  • Continental Strategy/Katie Wiles: the firm’s LDA client list, any White House or HHS contacts, and a first-hand statement from Katie Wiles or the firm.
  • Walker Barrett’s response; he is named repeatedly but no on-record response appears in the material reviewed.
  • Documentation for Means’s claim that Fabrizio was paid by Pepsi or Pfizer, and whether any such client relationship was connected to his advice on ultra-processed-food policy.
  • Whether any congressional committee has formally opened an inquiry, issued records requests or subpoenas, as distinct from Garcia’s statements about looking into the matter.
  • Whether any record ties Executive Order 14387, the FDA Glas authorization or May vape guidance to Wiles, Blair or Ballard beyond chronology.
SOURCES
  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.
  25. 25.
  26. 26.